The war on antidepressants: What we can, and can't conclude, from the systematic review of antidepressant withdrawal effects by Davies and Read.
作者信息
Jauhar Sameer, Hayes Joseph
机构信息
Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College, London, SE5 8 AF, UK.
Division of Psychiatry, University College London, UK.
出版信息
Addict Behav. 2019 Oct;97:122-125. doi: 10.1016/j.addbeh.2019.01.025. Epub 2019 Jan 23.
Abstract
摘要
相似文献
1
The war on antidepressants: What we can, and can't conclude, from the systematic review of antidepressant withdrawal effects by Davies and Read.
Addict Behav. 2019 Oct;97:122-125. doi: 10.1016/j.addbeh.2019.01.025. Epub 2019 Jan 23.
2
Corrigendum to "The war on antidepressants: What we can, and can't conclude, from the systematic review of antidepressant withdrawal effects by Davies and Read" [Addictive Behaviors (2019)].
Addict Behav. 2019 Oct;97:126. doi: 10.1016/j.addbeh.2019.05.015. Epub 2019 May 31.
3
Antidepressants: can't live with them, can't live without them.
CNS Spectr. 2010 Mar;15(3):146-7. doi: 10.1017/s1092852900027395.
4
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
5
A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?
Addict Behav. 2019 Oct;97:111-121. doi: 10.1016/j.addbeh.2018.08.027. Epub 2018 Sep 4.
6
Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.
Cochrane Database Syst Rev. 2021 Apr 15;4(4):CD013495. doi: 10.1002/14651858.CD013495.pub2.
7
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data.
CNS Drugs. 2023 Feb;37(2):143-157. doi: 10.1007/s40263-022-00960-y. Epub 2022 Dec 14.
8
Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review.
Mol Psychiatry. 2025 May;30(5):1758-1769. doi: 10.1038/s41380-024-02782-4. Epub 2024 Oct 11.
9
Antidepressants for depressed elderly.
Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD003491. doi: 10.1002/14651858.CD003491.pub2.
10
Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis.
Lancet Psychiatry. 2024 Jul;11(7):526-535. doi: 10.1016/S2215-0366(24)00133-0. Epub 2024 Jun 5.
引用本文的文献
1
Evidence on antidepressant withdrawal: an appraisal and reanalysis of a recent systematic review.
Psychol Med. 2025 Jul 22;55:e191. doi: 10.1017/S0033291725100652.
2
Trazodone once-a-day: A formula for addressing challenges in antidepressant safety and tolerability.
Neurosci Appl. 2023 May 22;2:101127. doi: 10.1016/j.nsa.2023.101127. eCollection 2023.
3
Acute carbamoylated erythropoietin reduces social stress-induced anxiety and depression-related behaviors.
Neuropharmacology. 2025 Jun 11;278:110558. doi: 10.1016/j.neuropharm.2025.110558.
4
Discontinuation of psychotropic medication: a synthesis of evidence across medication classes.
Mol Psychiatry. 2024 Aug;29(8):2575-2586. doi: 10.1038/s41380-024-02445-4. Epub 2024 Mar 19.
5
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data.
CNS Drugs. 2023 Feb;37(2):143-157. doi: 10.1007/s40263-022-00960-y. Epub 2022 Dec 14.
6
Intermittent selective serotonin reuptake inhibitors for premenstrual syndromes: A systematic review and meta-analysis of randomised trials.
J Psychopharmacol. 2023 Mar;37(3):261-267. doi: 10.1177/02698811221099645. Epub 2022 Jun 10.
7
The 'patient voice': patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition.
Ther Adv Psychopharmacol. 2020 Nov 9;10:2045125320967183. doi: 10.1177/2045125320967183. eCollection 2020.
8
Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations.
Ther Adv Psychopharmacol. 2020 Jun 10;10:2045125320933404. doi: 10.1177/2045125320933404. eCollection 2020.
9
Antidepressant withdrawal - the tide is finally turning.
Epidemiol Psychiatr Sci. 2019 Aug 22;29:e52. doi: 10.1017/S2045796019000465.
10
Antidepressants, withdrawal, and addiction; where are we now?
J Psychopharmacol. 2019 Jun;33(6):655-659. doi: 10.1177/0269881119845799. Epub 2019 May 21.
本文引用的文献
1
A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?
Addict Behav. 2019 Oct;97:111-121. doi: 10.1016/j.addbeh.2018.08.027. Epub 2018 Sep 4.
2
Characteristics of Escitalopram Discontinuation Syndrome: A Preliminary Study.
Clin Neuropharmacol. 2016 May-Jun;39(3):125-7. doi: 10.1097/WNF.0000000000000139.
3
Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved.
Front Pharmacol. 2013 Apr 16;4:45. doi: 10.3389/fphar.2013.00045. eCollection 2013.
4
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64. doi: 10.7326/0003-4819-151-4-200908180-00135. Epub 2009 Jul 20.
5
The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study.
J Psychopharmacol. 2008 May;22(3):330-2. doi: 10.1177/0269881107081550.
6
Discontinuation symptoms in depression and anxiety disorders.
Int J Neuropsychopharmacol. 2007 Feb;10(1):73-84. doi: 10.1017/S1461145705006358. Epub 2005 Dec 19.
7
Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
J Clin Psychiatry. 2005 Oct;66(10):1312-20. doi: 10.4088/jcp.v66n1015.
8
A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.
J Clin Psychiatry. 2005 Oct;66(10):1270-8. doi: 10.4088/jcp.v66n1009.
9
Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study.
Int Clin Psychopharmacol. 2004 Sep;19(5):271-80. doi: 10.1097/01.yic.0000137184.64610.c8.
10
Tofranil-treatment of endogenous depressions.
Acta Psychiatr Scand. 1959;34(4):387-97. doi: 10.1111/j.1600-0447.1959.tb07529.x.
Zotero 插件